全文获取类型
收费全文 | 85374篇 |
免费 | 6254篇 |
国内免费 | 264篇 |
专业分类
耳鼻咽喉 | 997篇 |
儿科学 | 2174篇 |
妇产科学 | 1288篇 |
基础医学 | 11446篇 |
口腔科学 | 1014篇 |
临床医学 | 9146篇 |
内科学 | 18228篇 |
皮肤病学 | 1006篇 |
神经病学 | 8345篇 |
特种医学 | 3363篇 |
外科学 | 13545篇 |
综合类 | 1016篇 |
一般理论 | 96篇 |
预防医学 | 6404篇 |
眼科学 | 2102篇 |
药学 | 5771篇 |
中国医学 | 105篇 |
肿瘤学 | 5846篇 |
出版年
2023年 | 682篇 |
2022年 | 1074篇 |
2021年 | 2479篇 |
2020年 | 1419篇 |
2019年 | 2307篇 |
2018年 | 2638篇 |
2017年 | 1891篇 |
2016年 | 1989篇 |
2015年 | 2298篇 |
2014年 | 3344篇 |
2013年 | 4257篇 |
2012年 | 6757篇 |
2011年 | 7062篇 |
2010年 | 3852篇 |
2009年 | 3366篇 |
2008年 | 5648篇 |
2007年 | 5840篇 |
2006年 | 5460篇 |
2005年 | 5406篇 |
2004年 | 4882篇 |
2003年 | 4458篇 |
2002年 | 4071篇 |
2001年 | 810篇 |
2000年 | 623篇 |
1999年 | 734篇 |
1998年 | 833篇 |
1997年 | 636篇 |
1996年 | 542篇 |
1995年 | 474篇 |
1994年 | 441篇 |
1993年 | 414篇 |
1992年 | 362篇 |
1991年 | 334篇 |
1990年 | 313篇 |
1989年 | 280篇 |
1988年 | 258篇 |
1987年 | 243篇 |
1986年 | 254篇 |
1985年 | 250篇 |
1984年 | 265篇 |
1983年 | 224篇 |
1982年 | 285篇 |
1981年 | 268篇 |
1980年 | 203篇 |
1979年 | 152篇 |
1978年 | 159篇 |
1977年 | 142篇 |
1976年 | 99篇 |
1975年 | 91篇 |
1974年 | 91篇 |
排序方式: 共有10000条查询结果,搜索用时 8 毫秒
101.
102.
103.
This paper reports the findings from the first 2 years of the Belfast Youth Development Study. The Belfast Youth Development Study is a 5-year longitudinal investigation of the onset and development of adolescent drug using behaviours, the findings of the first 2 years from the study in relation to drug use patterns among the young people participating in the research are reported here. The findings show that while the majority of young people have not yet used an illicit substance, the study has seen a substantial increase in the numbers using such substances between year 1 and year 2. Boys still make up the majority of drug users in this period but there has been a substantial increase in the number of girls using illicit drugs and, more generally, an increase in the frequency of use among all those using such substances during this period. 相似文献
104.
105.
Janice C Probst Sarah B Laditka Jong-Yi Wang Andrew O Johnson 《BMC health services research》2007,7(1):40
Background
Travel burden is a key element in conceptualizing geographic access to health care. Prior research has shown that both rural and minority populations bear disproportionate travel burdens. However, many studies are limited to specific types of patient or specific locales. The purpose of our study was to quantify geographic and race-based differences in distance traveled and time spent in travel for medical/dental care using representative national data. 相似文献106.
M L Carr 《Catheterization and cardiovascular diagnosis》1988,14(3):182-205
We have given an overview of the management of the acute myocardial infarction patient utilizing the aggressive reperfusion techniques available today. Anatomic reperfusion rates have been over 95% with the combined methods described. The remaining problems technically are those of earlier reperfusion, methods to enhance myocardial recovery after ischemia, and prevention of restenosis or reocclusion. The use of laser methodology, coronary sinus retroperfusion, partial left heart bypass, and other innovative strategies may improve these results. The introduction of tissue plasminogen activator will affect our approach and will profoundly alter society's expectations of therapeutic success. Still, patients will die from acute myocardial infarction and its complications. The search for a prevention must, therefore, not be overshadowed by our current enthusiasm for reperfusion techniques. Hopefully, our current approach will become a historical footnote as breakthroughs in preventive strategies occur. 相似文献
107.
Deferred treatment for prostate cancer 总被引:2,自引:0,他引:2
The clinical outcome of 278 prostate cancer patients managed by a deferred treatment policy was analysed retrospectively. Following TURP or biopsy, all patients were asymptomatic and deemed suitable for management by a deferred treatment policy, i.e. hormone therapy or other forms of treatment were only initiated if and when symptomatic progression occurred. The overall 5-year survival rate was 30%; 18% of patients died from other causes without needing treatment for their prostate cancer; 11% were alive and untreated after 5 years' follow-up; 17% died from prostate cancer without further treatment. Poor tumour grade, anaemia, metastatic disease, a short history, presentation with retention, and a raised serum creatinine at presentation were associated with a poor prognosis. 相似文献
108.
109.
Steven D Billings Shaun V Walsh Cyril Fisher Asma Nusrat Sharon W Weiss Andrew L Folpe 《Modern pathology》2004,17(2):141-149
Synovial sarcoma demonstrates epithelial differentiation, either by light microscopy (biphasic synovial sarcoma) or by immunohistochemical/ultrastructural methods only (monophasic) and poorly differentiated synovial sarcoma. Although the glands of synovial sarcoma are known to have tight junction-like structures, far less is known about junction formation in the spindled component of synovial sarcomas. Additionally, it is unknown whether the tight junctions of synovial sarcoma are normally constituted. The tight junction is a multiprotein complex consisting of numerous proteins that include ZO-1, claudin-1 and occludin. A total of 35 cases of synovial sarcoma (13 biphasic, 14 monophasic and eight poorly differentiated) were immunostained for ZO-1, claudin-1 and occludin using commercially available antibodies, heat-induced epitope retrieval and standard avidin-biotin technique. When available, corresponding electron micrographs were reviewed. For five cases, the presence of either an SYT-SSX1 (three cases) or SYT-SSX2 (two cases) gene fusion was known. Positive cases showed particulate membrane staining. The glands of biphasic synovial sarcomas expressed ZO-1 (13/13), claudin-1 (12/13) and occludin (11/13) in a manner identical to normal glandular epithelia, at the apical portion of the lateral membrane. The spindle cells of biphasic synovial sarcomas showed abnormal circumferential membranous expression of ZO-1 (12/13), claudin-1 (6/13) and occludin (3/13). Monophasic synovial sarcomas expressed ZO-1 in a circumferential pattern (13/14) but less often claudin-1 (4/14) or occludin (3/14). Poorly differentiated synovial sarcomas expressed ZO-1 (8/8) and claudin-1 (6/8) but only rarely occludin (2/8). By electron microscopy, recognizable tight junctions were seen only in glands. No correlation was seen between histologic subtype or fusion type and expression of tight junction proteins. We conclude that the glands of biphasic synovial sarcomas show well-organized, true epithelial tight junctions. In contrast, the spindled cells of all synovial sarcomas show significant abnormalities in the expression and localization of tight junction proteins, suggesting partial and/or aberrant epithelial differentiation. 相似文献
110.
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials.
Vincent Meininger Gilbert Bensimon Walter R Bradley Benjamin Brooks Patrice Douillet Andrew A Eisen Lucette Lacomblez P Nigel Leigh Wim Robberecht 《Amyotrophic lateral sclerosis and other motor neuron disorders》2004,5(2):107-117
Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive and fatal motor neuron disease. We carried out two randomized, double-blind, placebo-controlled, multi-centre, multi-national studies with xaliproden (a drug with neurotrophic effect) to assess drug efficacy and safety at two doses. Patients with clinically probable or definite ALS of more than 6 months and less than 5 years duration were randomly assigned to placebo, 1 mg or 2 mg xaliproden orally once daily as monotherapy in Study 1 (n=867); or to the same regimen with addition of riluzole 50 mg bid background therapy in Study 2 (n=1210 patients). The two primary endpoints were defined as: 1. Time to death, tracheostomy, or permanent assisted ventilation (DTP), and 2. Time to vital capacity (VC)<50% or DTP before (log-rank test) and after adjustment using a Cox proportional hazard model for prespecified prognostic factors. Secondary endpoints were rates of change of various functional measures. In Study 1, primary outcome measures did not reach statistical significance. For the 2 mg group, for time to VC<50% analysis (without DTP) a significant 30% RRR was obtained (95% confidence interval [CI]: 8.46, P=0.009). In Study 2, no significant results were obtained. However, there was a trend in favour of add-on 1 mg dose xaliproden vs. placebo (RRR 15% [-6.31, ns] for time to VC<50%; RRR 12% [CI: -6.27, ns] for time to VC<50% or DTP). Adjusted RR ratios were consistently more favourable for the xaliproden groups. Tolerability was good, and dose-dependent side effects were largely associated with the serotonergic properties of xaliproden. An effect of xaliproden on functional parameters, especially VC, was noted. Although this effect did not reach statistical significance, xaliproden had a small effect on clinically noteworthy aspects of disease progression in ALS. 相似文献